ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Aug 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
October 2026
Nuclear Technology
September 2026
Fusion Science and Technology
August 2026
Latest News
Capitalizing on community
Mark Peterspresident@ans.org
One month into my term as president of the American Nuclear Society, it is already clear that the nuclear field continues to move quickly. June alone brought a striking number of developments, each one pointing to the momentum of this moment.
Antares’s Mark-0 microreactor reaching criticality at Idaho National Laboratory was more than a technical milestone. It effectively brought reactor No. 53 on line at a site that has shaped much of the nation’s nuclear history, with 52 reactors built there since 1951. And more criticality starts were delivered in June and July, enabled by the Department of Energy and its partnerships with private companies.
At the same time, the Nuclear Regulatory Commission is continuing its broad regulatory reform effort, and nuclear technology is being used to help combat an outbreak of New World screwworm that has spread to the United States.
Technical Session|Panel|Sponsored by NCSD
Wednesday, June 10, 2020|12:00–2:10PM EDT|10
Session Chair:
Katherin L. Goluoglu
Alternate Chair:
Brandon Little
Session Organizer:
Joseph A. Christensen
Staff Producer:
Paul LaTour (American Nuclear Society)
This session addresses the growing field of medical isotope production and the implications for criticality safety. The field involves a number of emerging techniques and technologies which produce criticality safety challenges, INCLUDING handling high-assay low-enriched uranium in known or new chemical compositions. These challenges create opportunities for advancements in criticality safety techniques and demonstrate a continuing need for nuclear data. This panel is designed to highlight challenges, advancements, and current or future needs in the field of criticality safety for medical isotope production facilities.
Jeff Chapman
National Nuclear Security Administration
Joseph Christensen
SHINE Medical Technologies
Katherin Goluoglu
Isotek Systems, LLC
To access the session recording, you must be logged in and registered for the meeting.
Register NowLog In